Cite
MLA Citation
Michael Staehler et al.. “First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial.” International journal of cancer, vol. 148, no. 4, 2021, pp. 950–960. http://access.bl.uk/ark:/81055/vdc_100117911190.0x00005a